[1]熊波波,张劲松,王海峰,等.miRNAs与泌尿系肿瘤关系的研究进展[J].医学信息,2019,(05):35-38.[doi:10.3969/j.issn.1006-1959.2019.04.013]
 XIONG Bo-bo,ZHANG Jin-song,WANG Hai-feng,et al.Research Progress on the Relationship between miRNAs and Urinary Tumors[J].Medical Information,2019,(05):35-38.[doi:10.3969/j.issn.1006-1959.2019.04.013]
点击复制

miRNAs与泌尿系肿瘤关系的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年05期
页码:
35-38
栏目:
综述
出版日期:
2019-03-01

文章信息/Info

Title:
Research Progress on the Relationship between miRNAs and Urinary Tumors
文章编号:
1006-1959(2019)05-0035-04
作者:
熊波波张劲松王海峰左毅刚王剑松
(昆明医科大学第二附属医院泌尿外科一病区,云南 昆明 650000)
Author(s):
XIONG Bo-boZHANG Jin-songWANG Hai-fengZUO Yi-gangWANG Jian-song
(Department of Urology,the Second Affiliated Hospital of Kunming Medical University,Kunming,650000,Yunnan,China)
关键词:
微小RNA 泌尿系肿瘤膀胱癌前列腺癌 肾癌miRNAs
Keywords:
MicroRNA urinary tumorBladder cancerProstate cancerKidney cancermiRNAs
分类号:
R737.1
DOI:
10.3969/j.issn.1006-1959.2019.04.013
文献标志码:
A
摘要:
近年来泌尿系肿瘤呈现逐年递增的模式,肾癌、膀胱癌、前列腺癌为泌尿系常见肿瘤,随着人们生活水平的不断提高及生活习性的改变,其死亡率与发病率亦逐年增加,具体发病机制尚未明确。死亡率和发病率增加也迫使泌尿系恶性肿瘤成为生物分子研究的热门话题。最近研究发现miRNAs与泌尿系肿瘤的发生,发展及预后有重要的价值,可作为泌尿系肿瘤的早期诊断、治疗及预后监测的途径。本文将对其近期国内外研究作一综述,以便提供给相关研究人员为参考。
Abstract:
In recent years, urinary tract tumors have been increasing year by year. Kidney cancer, bladder cancer and prostate cancer are common urinary tumors. With the improvement of people’s living standards and changes in living habits, the mortality and morbidity rate have increased year by year. The pathogenesis is not yet clear. Increased mortality and morbidity also force urinary malignancies to become a hot topic in biomolecular research. Recent studies have found that miRNAs have important value in the occurrence, development and prognosis of urinary tumors, and can be used as a way to diagnose, treat and prognose urinary tumors. This article will review its recent research at home and abroad for reference to relevant researchers.

参考文献/References:


[1]Berindan-Neagoe I,Monroig PC,Pasculli B,et al.MicroRNAome genome:a treasure for cancer diagnosis and therapy[J].CA Cancer J Clin,2014,64(5):311-336.
[2]Liu X,Liu X,Wu Y,et al.MicroRNAs in biofluids are novel tools for bladder cancer screening[J]. Oncotarget,2017,8(19):32370-32379.
[3]Horvitz HR,Sulston JE.Isolation and genetic characterization of cell-lineage mutants of the nematode Caenorhabditis elegans[J].Genetics,1980,96(2):435-454.
[4]Di LG,Garofalo M,Croce CM.MicroRNAs in cancer[J].Annu Rev Pathol,2014(9):287-314.
[5]Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
[6]MMJ M,Ghanbari M.Cell Cycle Regulation of Stem Cells by MicroRNAs[J].Stem Cell Rev,2018,14(3):309-322.
[7]Monroig PD,Calin GA.MicroRNA and Epigenetics:Diagnostic and Therapeutic Opportunities[J]. Curr Pathobiol Rep,2013, 1(1):43-52.
[8]Asangani IA,Rasheed SA,Nikolova DA,et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion,intravasation and metastasis in colorectal cancer[J].Oncogene,2008,27(15):2128-2136.
[9]Calin GA,Dumitru CD,Shimizu M,et al.Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J].Proc Natl Acad Sci USA,2002,99(24):15524-15529.
[10]Akkafa F,Koyuncu I,Temiz E,et al.miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line[J].Biochem Biophys Res Commun,2018,503(1):323-329.
[11]Han X,Wang X,Zhao B,et al.MicroRNA-187 inhibits tumor growth and metastasis via targeting of IGF-1R in hepatocellular carcinoma[J].Mol Med Rep,2017,16(2):2241-2246.
[12]Minami K,Taniguchi K,Sugito N,et al.MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells[J].Oncotarget,2017,8(20):33064-33077.
[13]Zhou X,Yue Y,Wang R,et al.MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells[J].Int J Oncol,2017,50(3):853-862.
[14]Sheng N,Tan G,You W,et al.MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway[J].Cancer Med,2017,6(6):1331-1340.
[15]Mei LL,Wang WJ,Qiu YT,et al.miR-145-5p Suppresses Tumor Cell Migration,Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma[J].Int J Mol Sci,2017,18(9).
[16]Chen E,Li Q,Wang H,et al.MiR-92a promotes tumorigenesis of colorectal cancer,a transcriptomic and functional based study[J].Biomed Pharmacother,2018(106):1370-1377.
[17]Zhang Q,Miao S,Han X,et al.MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21[J].Cell Death Dis,2018,9(10):960.
[18]Zhao F,Zhou LH,Ge YZ,et al.MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle[J].J Cell Physiol,2019,234(4):4910-4923.
[19]Li J,Qiu M,An Y,et al.miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3[J].Biochem Biophys Res Commun,2018,503(3):2101-2107.
[20]Li Z,Zhou L,Lin C,et al.MiR-302b regulates cell functions and acts as a potential biomarker to predict recurrence in bladder cancer[J].Life Sci,2018(209):15-23.
[21]Feng C,Sun P, Hu J,et al.miRNA-556-3p promotes human bladder cancer proliferation,migration and invasion by negatively regulating DAB2IP expression[J].Int J Oncol,2017,50(6):2101-2112.
[22]Dybos SA,Flatberg A,Halgunset J,et al.Increased levels of serum miR-148a-3p are associated with prostate cancer[J].APMIS,2018,126(9):722-731.
[23]Meng FJ,Meng FM,Wu HX,et al.miR-564 inhibited metastasis and proliferation of prostate cancer by targeting MLLT3[J].Eur Rev Med Pharmacol Sci,2017,21(21):4828-4834.
[24]Zhiping C,Shijun T,Linhui W,et al.MiR-181a promotes epithelial to mesenchymal transition of prostate cancer cells by targeting TGIF2[J].Eur Rev Med Pharmacol Sci,2017,21(21):4835-4843.
[25]Tinay I,Tan M,Gui B,et al.Functional roles and potential clinical application of miRNA-345-5p in prostate cancer[J].Prostate,2018,78(12):927-937.
[26]Magee RG,Telonis AG,Loher P,et al.Profiles of miRNA Isoforms and tRNA Fragments in Prostate Cancer[J].Sci Rep,2018,8(1):5314.
[27]Nogueira I,Dias F,Teixeira AL,et al.miRNAs as potential regulators of mTOR pathway in renal cell carcinoma[J].Pharmacogenomics,2018,19(3):249-261.
[28]Wang M,Gao H,Qu H,et al.MiR-137 suppresses tumor growth and metastasis in clear cell renal cell carcinoma[J].Pharmacol Rep,2018,70(5):963-971.
[29]Wang C,Cai L,Liu J,et al.MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression[J].Cell Physiol Biochem,2017,43(6):2405-2419.
[30]Song H,Nan Y,Wang X,et al.MicroRNA?613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7[J].Mol Med Rep,2017,16(4):4279-4286.
[31]Yang F,Ma J,Tang Q,et al.MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Krüppel-like factor 6[J].Biomed Pharmacother, 2018(97):616-623.
[32]Lai Y,Zhao L,Hu J,et al. microRNA?181a?5p functions as an oncogene in renal cell carcinoma[J]. Mol Med Rep,2018,17(6):8510-8517.
[33]Motawi TK,Rizk SM,Ibrahim TM,et al.Circulating microRNAs,miR-92a,miR-100 and miR-143,as non-invasive biomarkers for bladder cancer diagnosis[J].Cell Biochem Funct,2016,34(3):142-148.
[34]Feng Y,Liu J,Kang Y,et al.miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer[J].J Exp Clin Cancer Res,2014(33):67.
[35]Zheng H,Guo Z,Zheng X,et al. MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55[J]. Am J Transl Res,2018,10(8):2457-2468.
[36]Yamada Y,Arai T,Sugawara S,et al.Impact of novel oncogenic pathways regulated by anti-tumor miR-451a in renal cell carcinoma[J].Cancer Science,2018,109(4):1239.
[37]Pan X,Li Z,Zhao L,et al.microRNA?572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis[J].Oncol Rep,2018,40(5):3092-3101.
[38]Pan X,Quan J,Li Z,et al.miR-566 functions as an oncogene and a potential biomarker for prognosis in renal cell carcinoma[J].Biomed Pharmacother,2018(102):718-727.

相似文献/References:

[1]幸世玉.经尿道电切术联合吉西他滨灌注治疗膀胱癌的临床效果分析[J].医学信息,2018,(20):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]
 XING Shi-yu.Clinical Analysis of Transurethral Resection Combined with Gemcitabine Perfusion in the Treatment of Bladder Cancer[J].Medical Information,2018,(05):91.[doi:10.3969/j.issn.1006-1959.2018.20.026]

更新日期/Last Update: 2019-03-01